4//SEC Filing
REICIN ALISE 4
Accession 0001562180-23-005031
CIK 0001770121other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:34 PM ET
Size
9.5 KB
Accession
0001562180-23-005031
Insider Transaction Report
Form 4
REICIN ALISE
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+65,000→ 65,000 totalExercise: $6.70Exp: 2033-06-07→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 8, 2024 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 8, 2023.
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001757533
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:34 PM ET
- Size
- 9.5 KB